Dong-A ST's Obesity Drug Candidate DA-1726 Shows Reduced Blood Uric Acid in Phase 1 Trial
AI 요약 정보
- MetaVia reports significant Phase 1 uric acid drop on DA-1726
- DA-1726's 16-week change: 1.47 mg/dL below placebo
- MetaVia plans 48-week Phase 2, up to 150 patients, in H2 2027